Effects of the "Spinomed Active" Orthosis on Chronic Back Pain in Women With Vertebral Fractures.

NCT ID: NCT04854629

Last Updated: 2022-01-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-04-07

Study Completion Date

2022-01-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Osteoporotic vertebral fractures often lead to postural changes, chronic spinal pain conditions and limited functionality. Orthoses that straighten the spine have been shown in studies to have a positive effect on pain, posture and the functional state of patients with a fresh vertebral fracture.

The planned study investigates the effect of the orthosis "Spinomed active" in patients aged ≥ 65 years with at least one non-acute osteoporotic vertebral fracture (at least 3 months ago) and chronic back pain.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Osteopenia Kyphosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized controlled trial with two study groups in parallel: (1) Spinomed active orthosis or 16 weeks (2) non spinomed active orthosis control
Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Outcome Assessors
Outcomes assessor were unaware of participant status (i.e. spinomed active or control) and were not allowed to ask correspondingly

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Spinomed active orthosis

Wearing the orthosis for 16 weeks

Group Type EXPERIMENTAL

Spinomed active

Intervention Type OTHER

Wearing of the orthosis 2-3 h/twice a day for 16 weeks Supplementation of a maximum of 1000 mg/d calcium and 800 IE/d vitamin D

Control group

No intervention: non spinomed active control

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Spinomed active

Wearing of the orthosis 2-3 h/twice a day for 16 weeks Supplementation of a maximum of 1000 mg/d calcium and 800 IE/d vitamin D

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Living independently in the community
* ≥ 1 low-traumatic vertebral fracture ≥ 3 months ago
* Chronic back pain according to the national guideline for low back pain
* Mean back pain intensity NPS ≥ 1 (1-10 scale)
* Hyperkyphosis, kyphosis angle according to Debrunner \>40°
* Intact skin or adequate wound coverage in the area of the contact surface of the orthosis

Exclusion Criteria

* Secondary osteoporosis (as determined by study physician)
* Expected change in overall pain therapy during the study period
* Structurally fixed kyphosis, lack of extension ability of the thoracic spine
* Kyphoplasty, vertebroplasty
* Use of back orthoses during the last 6 months
* Depression
* Dementia, cognitive impairment (Mini Mental Test \< 25)
* Fresh neurological deficits; incontinence \> grade 1
* Body dimensions that do not allow for adjustment of the back orthosis
* Absence during baseline and follow-up assessments
Minimum Eligible Age

65 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

medi GmbH & Co. KG, Bayreuth, Germany

UNKNOWN

Sponsor Role collaborator

University of Erlangen-Nürnberg Medical School

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Wolfgang Kemmler, PhD

Role: STUDY_CHAIR

Institute of Medical Physics, Friedrich-Alexander University of Erlangen-Nürnberg

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Institute of Medical Physics University of Erlangen-Nurnberg

Erlangen, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Orthosis Spinomed active

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Karma Ambispective Study
NCT07207187 ENROLLING_BY_INVITATION
Cervical Spondylotic Myelopathy Surgical Trial
NCT02076113 ACTIVE_NOT_RECRUITING NA